Codes / ICD10CM / M1A.1710

M1A.1710 Lead-induced chronic gout, right ankle and foot, without tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Right Ankle and Foot, Without Tophus (Tophi)

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to elevated uric acid levels and recurrent joint inflammation. This specific presentation affects the right ankle and foot, resulting in persistent symptoms without the formation of tophi (urate crystal deposits). Untreated, it may cause tissue damage and functional impairment.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term occupational or environmental lead exposure
  • History of gout or hyperuricemia
  • Male gender
  • Middle-aged or older adults
  • Impaired kidney function

Symptoms

  • Recurrent episodes of intense joint pain in the right ankle or foot
  • Persistent swelling, redness, and warmth in the affected area
  • Stiffness and limited mobility in the right ankle or foot
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage and confirms the right ankle and foot involvement, excluding tophi presence.

Treatment Options

  • Medications such as non-steroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation
  • Urate-lowering therapies (e.g., allopurinol) to reduce uric acid levels
  • Lead exposure reduction or removal to prevent further accumulation
  • Lifestyle modifications (e.g., dietary changes) to manage uric acid levels

Prognosis and Follow-Up

With proper treatment, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels, adjust medications, and assess for complications. Untreated cases may progress to chronic joint damage or disability.

Complications

  • Chronic joint damage or deformity in the right ankle or foot
  • Persistent pain and reduced mobility
  • Increased risk of future gout flares
  • Potential kidney involvement from prolonged hyperuricemia

Lifestyle & Prevention

  • Avoid or limit lead exposure (e.g., occupational safety measures)
  • Maintain a balanced diet low in purines (e.g., limit red meat, alcohol)
  • Stay hydrated to support uric acid excretion
  • Follow medical advice for lead exposure testing and monitoring

When to Seek Professional Help

Seek care if experiencing severe or persistent joint pain, swelling, or stiffness in the right ankle or foot, especially with flare-ups. Prompt evaluation is needed to confirm diagnosis and initiate treatment to prevent complications.

Tips for Medical Coders

Document the specific site (right ankle and foot) and absence of tophi to support code M1A.1710. Ensure clinical notes specify the affected area and lack of tophaceous deposits, as these details are critical for accurate coding. Verify that lead exposure is documented as the underlying cause to align with the code’s etiology.

Book a walkthrough

M1A.1710 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.